Position in MEDP
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$20,308,675
+$19,989,080 QoQ
Shares Held
42,293
+5350.1% QoQ
Ownership
0.152%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MEDP Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Balyasny Asset Management L.P. holds $727,123,354 across 18 Diagnostics & Research names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
449,628 | $225,425,494 | |
| 2 | DHR |
Danaher Corp /De/
|
759,207 | $144,613,749 | |
| 3 | IQV |
Iqvia Holdings Inc.
|
700,425 | $135,336,117 | |
| 4 | MTD |
Mettler Toledo International Inc/
|
54,686 | $69,861,911 | |
| 5 | DGX |
Quest Diagnostics Inc
|
275,371 | $58,364,883 | |
| 6 | WAT |
Waters Corp /De/
|
138,443 | $51,921,662 | |
| 7 | GH |
Guardant Health, Inc.
|
124,368 | $18,658,930 | |
| 8 | RVTY |
Revvity, Inc.
|
63,056 | $7,015,610 |
All Filings in MEDP
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $20,308,675 | 42,293 | Shares | Sole | 2026-05-15 | |
| 2024-06-30 | $319,595 | 776 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $407,787 | 1,009 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $362,624 | 1,183 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $5,404,825 | 22,322 | Shares | Other | 2023-11-14 | |
| 2020-06-30 | $1,029,452 | 11,067 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||